Life Sciences

Novo Nordisk Foundation’s $260M Initiative Targets Enhanced Respiratory Vaccines

Novo Nordisk Foundation’s $260M Initiative Targets Enha...

Dec 18, 2023

In a major move, the Novo Nordisk Foundation is allocating $260 million to pione...

Checkpoint Therapeutics Faces FDA Setback, but Optimism Persists for Skin Cancer Therapy

Checkpoint Therapeutics Faces FDA Setback, but Optimism...

Dec 18, 2023

Checkpoint Therapeutics, headquartered in Waltham, Massachusetts, recently encou...

Pharvaris’ hereditary angioedema medication reduces attacks in the wake of the FDA hold

Pharvaris’ hereditary angioedema medication reduces att...

Dec 18, 2023

Pharvaris has reported a significant breakthrough in the treatment of hereditary...

Unveiling Weight Regain Trends in Eli Lilly’s Zepbound Study

Unveiling Weight Regain Trends in Eli Lilly’s Zepbound ...

Dec 18, 2023

Patients taking Eli Lilly’s weight loss drug Zepbound faced a substantial weight...

Bristol Myers’ Opdivo and Cisplatin Combination Achieves Breakthrough in Initial Colorectal Cancer Treatment

Bristol Myers’ Opdivo and Cisplatin Combination Achieve...

Dec 14, 2023

A notable development has occurred in the initial treatment of colorectal cancer...

Poseida’s Roche-Backed Off-the-Shelf CAR-T Shows Promise Amid FDA Concerns

Poseida’s Roche-Backed Off-the-Shelf CAR-T Shows Promis...

Dec 14, 2023

In response to the FDA’s recent safety review of approved CAR-T therapies, Posei...

NeuroOne Grabs FDA Clearance For Ablation Tech

NeuroOne Grabs FDA Clearance For Ablation Tech

Dec 14, 2023

NeuroOne has now received another agency nod that expands upon the capabilities ...

FDA Approves Gene Therapies for Sickle Cell Treatment

FDA Approves Gene Therapies for Sickle Cell Treatment

Dec 14, 2023

In a move that marks a significant advancement in the treatment of sickle cell d...

Microscopic “super bots” repair neural wound model

Microscopic “super bots” repair neural wound model

Dec 6, 2023

In a recent development, scientists have brought science fiction to life by crea...

Lilly’s Jaypirca leads the leukemia trail with FDA approval

Lilly’s Jaypirca leads the leukemia trail with FDA appr...

Dec 6, 2023

In the highly competitive landscape of BTK inhibitors for blood cancer treatment...

Merus Faces Setback Following Interim Report for Lung Cancer Therapy

Merus Faces Setback Following Interim Report for Lung C...

Dec 6, 2023

Merus, a biopharmaceutical company, confronted a significant setback following a...

Merck’s Evobrutinib Encounters Setbacks in MS Trials Amid BTK Inhibitor Challenges

Merck’s Evobrutinib Encounters Setbacks in MS Trials Am...

Dec 6, 2023

Merck KGaA’s foray into the competitive BTK inhibitor space has hit a roadblock,...

Roche’s $2.7 Billion Move into the Obesity Market Acquisition of Carmot Therapeutics

Roche’s $2.7 Billion Move into the Obesity Market Acqui...

Dec 4, 2023

Roche has made a resounding entry into the obesity market with a whopping upfron...

Lung Cancer Data from AbbVie Paves Way for Accelerated ADC Approval, Falls Below Initial Benchmark

Lung Cancer Data from AbbVie Paves Way for Accelerated ...

Dec 2, 2023

AbbVie is actively seeking accelerated approval for its promising c-Met antibody...

Amgen Expands Amazon Partnership to Seek Generative AI Solutions

Amgen Expands Amazon Partnership to Seek Generative AI ...

Nov 30, 2023

In a concerted effort to enhance the discovery and manufacturing processes of ph...

Roivant Bids Farewell to Lupus Treatment Following Phase 2 Failure

Roivant Bids Farewell to Lupus Treatment Following Phas...

Nov 30, 2023

Roivant CEO Matt Gline had never been too confident of lupus drug brepocitinib. ...

21
22
23
24
25